StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.95−0.09 (-4.41%)

Close on Nov 17, 2026Market cap $2.94MP/E –Yield –

Apimeds Pharmaceuticals US gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Apimeds Pharmaceuticals US

Apimeds Pharmaceuticals US has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?